Lifted Made Recoups Losses in Agreement with Disposable Vape Device Manufacturer

Jan.04.2023
Lifted Made Recoups Losses in Agreement with Disposable Vape Device Manufacturer
CBD brand Lifted Made agrees deal with e-cigarette manufacturer, recovering over $1 million in losses.

Lifted Made, a CBD brand under LFTD Partners, has reached an agreement with a third-party manufacturer of disposable e-cigarettes. This will allow Lifted Made to recover its losses, slightly exceeding $1 million, related to clogging issues with the disposable e-cigarette devices.


Lifted Made confirmed the existence of these defective devices in the third quarter of 2022.


According to a press release, an unknown overseas manufacturer of disposable smoking products has agreed to write off the outstanding debt of $630,000 owed by Lifted Made. Additionally, the manufacturer has committed to providing Lifted Made with a credit line for future purchases at a price of $185,023 per year in both 2023 and 2024, with a total value of $370,047.


Nick Warrender, CEO of Lifted Made and Vice President and Chief Operating Officer of LFTD Partners, stated that the company has a strong relationship with a manufacturer of disposable vape devices.


They are willing to share the losses we suffered in the third quarter due to the blockage of our 2mL vape device and this really proves that they are a good partner. We look forward to a very bright future with them," said Warrender. "Our new and award-winning 3mL disposable vape device has indeed been welcomed by our customers. We are very excited for 2023 and everything ahead as we enter the new year.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts Insight | Official Websites as Marketing Platforms: LOST MARY and OXVA Engage Users through Content and Interaction
2Firsts Insight | Official Websites as Marketing Platforms: LOST MARY and OXVA Engage Users through Content and Interaction
E-cigarette brands LOST MARY and OXVA launched new website features. LOST MARY’s “FLAVOR DISCOVERY” uses virtual characters for flavor matching, while OXVA’s “OX Chill” summer challenge boosts engagement with points, lotteries, and national rankings.
Jul.18 by 2FIRSTS.ai
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai
Smoore International Issues 2025 Interim Profit Warning: First-Half Earnings Expected to Drop 21%–35% YoY
Smoore International Issues 2025 Interim Profit Warning: First-Half Earnings Expected to Drop 21%–35% YoY
Smoore International has issued a profit warning, expecting net profit for the six months ended June 30, 2025, to decline by approximately 21% to 35% year-on-year, projected to range between 443 million and 541 million yuan.
Jul.16 by 2FIRSTS.ai
Kyrgyzstan Eyes Tobacco Tax Hikes as Core Strategy to Curb Smoking
Kyrgyzstan Eyes Tobacco Tax Hikes as Core Strategy to Curb Smoking
Kyrgyz health authorities and WHO experts urge stronger tobacco taxation to curb smoking and ease the economic impact of noncommunicable diseases.
Jun.11 by 2FIRSTS.ai
Product Roundup | Nicotine Oral Films and Lozenges Featured at Dubai Vape Show
Product Roundup | Nicotine Oral Films and Lozenges Featured at Dubai Vape Show
As the event’s official media partner, 2Firsts conducted in-depth visits across the exhibition halls and observed that several brands launched nicotine oral films and other innovative oral products.
Jun.20
On the Global Tobacco Battlefield: The Clash Between Science and Misinformation — A Tobacco Harm Reduction Expert’s Contribution to 2Firsts
On the Global Tobacco Battlefield: The Clash Between Science and Misinformation — A Tobacco Harm Reduction Expert’s Contribution to 2Firsts
In this in-depth contribution to 2Firsts, harm reduction expert Harry Shapiro exposes the misinformation and bias in global tobacco control, calling for evidence-based safer nicotine alternatives to protect public health and save lives.
Jul.08